Total Payments
$786.75
2024 Payments
$27.16
Companies
12
Transactions
29
Medicare Patients
2,777
Medicare Billing
$672,708
Payment Breakdown by Category
Food & Beverage$760.33 (96.6%)
Education$26.42 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $760.33 | 28 | 96.6% |
| Education | $26.42 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $337.06 | 10 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $84.70 | 4 | $0 (2022) |
| ABBVIE INC. | $80.08 | 3 | $0 (2022) |
| Alcon Vision LLC | $45.51 | 2 | $0 (2022) |
| Shire North American Group Inc | $44.56 | 2 | $0 (2019) |
| RxSight Inc | $44.46 | 2 | $0 (2023) |
| Alcon Laboratories Inc | $39.09 | 1 | $0 (2018) |
| Amgen Inc. | $27.16 | 1 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $25.37 | 1 | $0 (2019) |
| Carl Zeiss Meditec, Inc. | $24.52 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.16 | 1 | Amgen Inc. ($27.16) |
| 2023 | $24.93 | 1 | RxSight Inc ($24.93) |
| 2022 | $169.26 | 7 | ABBVIE INC. ($80.08) |
| 2021 | $20.46 | 1 | Novartis Pharmaceuticals Corporation ($20.46) |
| 2020 | $118.97 | 5 | Regeneron Healthcare Solutions, Inc. ($80.64) |
| 2019 | $325.47 | 10 | Regeneron Healthcare Solutions, Inc. ($219.53) |
| 2018 | $100.50 | 4 | Alcon Laboratories Inc ($39.09) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/27/2023 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/09/2022 | Alcon Vision LLC | rocklatan (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Glaucoma | ||||||
| 08/31/2022 | RxSight Inc | LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Ophthalmology | ||||||
| 08/09/2022 | ABBVIE INC. | RESTASIS MULTIDOSE (Drug), VUITY | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: DRY EYE | ||||||
| 07/19/2022 | ABBVIE INC. | RESTASIS MULTIDOSE (Drug), VUITY | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: DRY EYE | ||||||
| 05/31/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/04/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/28/2022 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Ophthalmology | ||||||
| 07/12/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/11/2020 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/01/2020 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/24/2020 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $18.58 | General |
| Category: Ophthalmology | ||||||
| 02/10/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/14/2020 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/25/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/01/2019 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: RETINA | ||||||
| 10/09/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/04/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $112.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/19/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/13/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Education | In-kind items and services | $26.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/10/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: OPTHALMICS | ||||||
| 06/06/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/12/2019 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug) | Food and Beverage | Cash or cash equivalent | $25.37 | General |
| Category: Ophthalmology | ||||||
| 01/07/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: OPTHALMICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 459 | 928 | $208,820 | $51,643 |
| 2022 | 4 | 282 | 398 | $107,260 | $25,936 |
| 2021 | 7 | 213 | 236 | $97,208 | $34,118 |
| 2020 | 14 | 1,823 | 3,771 | $1.4M | $561,011 |
Total Patients
2,777
Total Services
5,333
Medicare Billing
$672,708
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 144 | 270 | $101,250 | $27,614 | 27.3% |
| 92134 | Imaging of retina | Office | 2023 | 139 | 299 | $35,310 | $10,171 | 28.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 16 | 50 | $25,000 | $4,995 | 20.0% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 132 | 246 | $39,360 | $4,955 | 12.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 16 | 50 | $4,000 | $2,856 | 71.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 12 | 13 | $3,900 | $1,053 | 27.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 88 | 124 | $46,500 | $14,158 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 44 | $16,500 | $4,851 | 29.4% |
| 92134 | Imaging of retina | Office | 2022 | 84 | 128 | $27,940 | $4,717 | 16.9% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 80 | 102 | $16,320 | $2,210 | 13.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 17 | 38 | $57,000 | $25,840 | 45.3% |
| 67028 | Injection of drug into eye | Office | 2021 | 31 | 32 | $8,646 | $2,415 | 27.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 41 | 41 | $10,250 | $1,875 | 18.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 56 | 57 | $11,172 | $1,466 | 13.1% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 29 | 29 | $3,915 | $1,336 | 34.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2021 | 14 | 14 | $1,400 | $757.58 | 54.1% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 25 | 25 | $4,825 | $428.29 | 8.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2020 | 46 | 472 | $706,500 | $348,519 | 49.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 566 | 837 | $209,250 | $83,663 | 40.0% |
| 67028 | Injection of drug into eye | Office | 2020 | 102 | 480 | $126,022 | $42,608 | 33.8% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 436 | 1,064 | $208,541 | $36,681 | 17.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2020 | 56 | 240 | $24,200 | $14,890 | 61.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 154 | 182 | $31,850 | $12,476 | 39.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 87 | 87 | $21,750 | $9,807 | 45.1% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 85 | 92 | $12,420 | $4,979 | 40.1% |
About Xiang Werdich, MD, PHD
Xiang Werdich, MD, PHD is a Retina Specialist healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1124289749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Xiang Werdich, MD, PHD has received a total of $786.75 in payments from pharmaceutical and medical device companies, with $27.16 received in 2024. These payments were reported across 29 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($760.33).
As a Medicare-enrolled provider, Werdich has provided services to 2,777 Medicare beneficiaries, totaling 5,333 services with total Medicare billing of $672,708. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Internal Medicine, Ophthalmology
- Location Boston, MA
- Active Since 06/17/2008
- Last Updated 01/30/2024
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1124289749
Products in Payments
- EYLEA (Biological) $300.17
- XIIDRA (Drug) $129.26
- RESTASIS MULTIDOSE (Drug) $50.60
- ORA (Device) $39.09
- EYLEA AFLIBERCEPT INJECTION (Biological) $36.89
- VUITY (Drug) $29.48
- Simbrinza (Drug) $29.43
- TEPEZZA (Biological) $27.16
- XELPROS (Drug) $25.37
- RXSIGHT CONTACT LENS (Device) $24.93
- IOLMaster 500 (Device) $24.52
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) $19.53
- Omidria (Drug) $18.58
- rocklatan (Drug) $16.08
- OZURDEX (Drug) $15.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Retina Specialist Doctors in Boston
Lauren Bierman, M.d, M.D
Retina Specialist — Payments: $51,629
Retina Specialist $51,629
Avnish Deobhakta
Retina Specialist — Payments: $45,794
Retina Specialist $45,794
Siamak Shokrollahi
Retina Specialist — Payments: $2,339
Retina Specialist $2,339
Dr. Omar Abdelal, Md, MD
Retina Specialist — Payments: $2,060
Retina Specialist $2,060
Dr. Alex Pisig, M.d, M.D
Retina Specialist — Payments: $2,034
Retina Specialist $2,034
Dr. Vasiliki Poulaki, M.d, M.D
Retina Specialist — Payments: $1,716
Retina Specialist $1,716